Management of acute liver failure: update 2022
S Tujios, RT Stravitz, WM Lee - Seminars in liver disease, 2022 - thieme-connect.com
Abbreviated pathogenesis and clinical course of the acute liver failure syndrome. The
pathogenesis and clinical course of the syndrome of acute liver failure (ALF) differs …
pathogenesis and clinical course of the syndrome of acute liver failure (ALF) differs …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Acute liver failure
Acute liver failure (ALF) is a life-threatening disorder characterised by rapid deterioration of
liver function, coagulopathy, and hepatic encephalopathy in the absence of pre-existing liver …
liver function, coagulopathy, and hepatic encephalopathy in the absence of pre-existing liver …
Acute liver failure
F Vasques, A Cavazza, W Bernal - Current Opinion in Critical …, 2022 - journals.lww.com
Acute liver failure : Current Opinion in Critical Care Acute liver failure : Current Opinion in
Critical Care Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
Critical Care Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis
Plasma exchange (PE) is a promising therapeutic option in patients with acute liver failure
(ALF) and acute-on-chronic liver failure (ACLF). However, the impact of PE on patient …
(ALF) and acute-on-chronic liver failure (ACLF). However, the impact of PE on patient …
Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort
Background & Aims Therapeutic plasma exchange (PEX) has emerged as a potential
treatment option for patients with acute liver failure (ALF). The effect of PEX on survival …
treatment option for patients with acute liver failure (ALF). The effect of PEX on survival …
A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock
R Maiwall, SSR Pasupuleti, AK Hidam, A Kumar… - Journal of …, 2023 - Elsevier
Background & Aims A high mean arterial pressure (MAP) target has been associated with
improved renal outcomes in patients with cirrhosis, though it has not been studied in …
improved renal outcomes in patients with cirrhosis, though it has not been studied in …
Association between systemic immune inflammation index and short term prognosis of acute on chronic liver failure
Y Ma, Y Xu, L Du, L Bai, H Tang - Scientific Reports, 2024 - nature.com
The systemic immune-inflammatory index (SII) has been identified as an independent
prognostic factor for multiple diseases. However, the impact of SII on outcome of acute-on …
prognostic factor for multiple diseases. However, the impact of SII on outcome of acute-on …
Growing evidence for survival benefit with plasma exchange to treat liver failure
A Goel, U Zachariah, D Daniel, CE Eapen - Journal of Clinical and …, 2023 - Elsevier
Plasma exchange (PLEX) to treat liver failure patients is gaining increasing momentum in
recent years. Most reports have used PLEX to treat patients with acute liver failure (ALF) or …
recent years. Most reports have used PLEX to treat patients with acute liver failure (ALF) or …
Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity
L Thomas, J Chandran, A Goel, E Jacob… - Journal of Clinical and …, 2023 - Elsevier
Background In a prior report, no patient with rodenticidal hepatotoxicity who met Kochi
criteria (MELD score≥ 36 or baseline INR≥ 6 with hepatic encephalopathy)(PMID …
criteria (MELD score≥ 36 or baseline INR≥ 6 with hepatic encephalopathy)(PMID …